Stago, the worldwide leader in the field of Haemostasis is setting the standard of excellence, with cutting-edge technologies, products and customer service.
The United Kingdom is one of the countries where research is the most advanced in the field of coagulation and the demand for new technologies is great. In January 2005, the subsidiary Stago UK was opened.
Stago UK offers a complete system of Haemostasis instrumentation and optimized reagent kits for research as well as for routine analysis. We provide the means and the tools to the scientists and clinicians to diagnose and to understand the reasons of Thrombosis or Bleeding disorder.
The Core Values of our organisation remain the foundation of our business:
By implementing these core values since 2005, Stago UK:
Trinity Biotech coagulation business was acquired by Stago Group on May 4th 2010. It was renamed as Tcoag.
In the United Kingdom, Tcoag and Stago came together and Stago UK has been operating for both products portfolio, since January 2011.
This synergy between both organisations will progressively lead to: